IRIS UniCatt

Martinotti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.920
NA - Nord America 7.817
AS - Asia 4.047
SA - Sud America 744
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 97
OC - Oceania 38
Totale 21.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.639
IT - Italia 4.376
SG - Singapore 1.845
DE - Germania 1.719
CN - Cina 961
BR - Brasile 599
SE - Svezia 547
FR - Francia 537
UA - Ucraina 421
VN - Vietnam 359
GB - Regno Unito 314
NL - Olanda 195
IE - Irlanda 181
IN - India 164
FI - Finlandia 141
ID - Indonesia 122
RU - Federazione Russa 110
JP - Giappone 108
BD - Bangladesh 90
CA - Canada 89
HK - Hong Kong 86
TR - Turchia 75
CH - Svizzera 69
ES - Italia 56
PL - Polonia 55
MX - Messico 54
AR - Argentina 48
AU - Australia 31
BE - Belgio 31
IQ - Iraq 27
ZA - Sudafrica 24
RO - Romania 23
AT - Austria 21
IR - Iran 21
SA - Arabia Saudita 20
CL - Cile 19
CO - Colombia 18
VE - Venezuela 18
AL - Albania 16
EC - Ecuador 16
HU - Ungheria 15
MA - Marocco 15
CI - Costa d'Avorio 14
PK - Pakistan 14
CZ - Repubblica Ceca 13
NP - Nepal 13
IL - Israele 12
PH - Filippine 12
JO - Giordania 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
KR - Corea 9
LT - Lituania 9
TH - Thailandia 9
TW - Taiwan 9
EG - Egitto 8
GR - Grecia 8
KZ - Kazakistan 8
MT - Malta 8
PT - Portogallo 8
RS - Serbia 8
UZ - Uzbekistan 8
MY - Malesia 7
NZ - Nuova Zelanda 7
OM - Oman 7
TN - Tunisia 7
UY - Uruguay 7
AM - Armenia 6
DZ - Algeria 6
HR - Croazia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
LB - Libano 5
LV - Lettonia 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
JM - Giamaica 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NG - Nigeria 4
PY - Paraguay 4
BO - Bolivia 3
BZ - Belize 3
DK - Danimarca 3
ET - Etiopia 3
MC - Monaco 3
NO - Norvegia 3
QA - Qatar 3
BG - Bulgaria 2
BH - Bahrain 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 21.633
Salva come PNG Salva come JPEG
Città #
Singapore 946
Ashburn 784
Chandler 767
San Jose 664
Milan 518
Rome 446
Jacksonville 212
San Mateo 189
Dublin 172
Beijing 164
New York 154
Wilmington 147
Los Angeles 128
Nanjing 123
Ho Chi Minh City 119
Lauterbourg 115
Jakarta 108
Woodbridge 97
Hanoi 95
St Louis 94
The Dalles 85
Dearborn 83
Tokyo 79
Hefei 78
Nürnberg 76
Boston 72
Munich 72
Frankfurt am Main 71
Ann Arbor 67
Redwood City 67
Turin 66
Hong Kong 64
Bologna 61
Florence 61
Houston 60
Moscow 59
Dallas 58
Seattle 57
São Paulo 57
Lawrence 56
Marseille 56
Naples 56
Atlanta 52
Norwalk 50
Bremen 49
Nanchang 48
Santa Clara 47
Burlington 46
Chicago 44
Buffalo 43
Lancaster 42
Paris 42
Fairfield 41
Genoa 40
Princeton 40
Catania 38
Verona 37
Bari 36
Council Bluffs 36
Palermo 35
Brescia 34
Cattolica 34
Guangzhou 34
Helsinki 34
Boardman 33
Falls Church 32
University Park 30
Phoenix 29
Changsha 27
Mountain View 27
London 26
Memphis 26
Tianjin 26
Warsaw 26
Hebei 24
Toronto 24
Izmir 23
Brussels 22
Hangzhou 22
Mexico City 22
Shanghai 22
Chennai 20
Perugia 20
Shenyang 20
Brooklyn 19
Kent 19
Pune 19
Cambridge 18
Da Nang 18
Fremont 18
Haiphong 18
Orem 18
Denver 17
Messina 17
Padova 17
Cagliari 16
Modena 16
Montreal 16
Torino 16
Jiaxing 15
Totale 9.183
Salva come PNG Salva come JPEG
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 3.222
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 660
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 568
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report 554
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 495
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 421
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 370
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 364
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 331
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 330
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 293
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 280
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 274
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 268
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments 267
Resilience and childhood trauma in mood disorders: Psychopathological implications and treatment response 219
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 219
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 212
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 211
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 201
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 198
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 197
Problematic mobile phone use in adolescence: A cross-sectional study 196
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 190
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 181
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 180
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 180
Suicide by pencil 176
Alcohol protracted withdrawal syndrome: the role of anhedonia 174
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 169
Topiramate in Alcohol Use Disorders: Review and Update. 169
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 169
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 167
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 165
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 164
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 163
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 163
Behavioural addictions in adolescents and young adults: results from a prevalence study. 161
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 161
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 161
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 160
Il trattamento della schizofrenia 156
Oxcarbazepine in bipolar disorder: a critical review of the literature 153
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 153
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 152
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 150
Allostasis as a conceptual framework linking bipolar disorder and addiction 150
Behavioural addictions in adolescents and young adults: results from a prevalence study 149
Gabapentin as add-on treatment for somatoform disorder: a case report 146
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 144
Enhanced BDNF serum levels in patients with severe pathological gambling 143
Aripiprazole, alcohol and substance abuse: a review 142
Oxcarbazepine improves mood in patients with epilepsy 140
Cocaine use disorders and serum magnesium profile 138
Enhanced BDNF serum levels in patients with severe pathological gambling 137
Alcohol drinking patterns in young people: A survey-based study 137
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 137
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone 135
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 135
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 135
Oxcarbazepine improves mood in patients with epilepsy. 133
Dead under the bed: a case of Diogenes syndrome? 133
Amantadine in the treatment of pathological gambling: a case report 133
Who`s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 132
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 130
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 130
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 128
Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses 127
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? 127
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics 125
A possible new option for migraine management: agomelatine 125
‘Suicide on Italian Instagram: Insights and implications for prevention and support’ 124
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 124
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 124
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 123
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 122
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. 121
Empathy ability is impaired in alcohol-dependent patients 119
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 119
Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects 118
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 115
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 115
Prevalence and intensity of basic symptoms among cannabis users: an observational study 114
Anhedonia and substance dependence: clinical correlates and treatment options 113
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 111
Efficacy and safety of pregabalin in alcohol dependence 110
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study 109
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients 108
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 108
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 106
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 105
Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. 103
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. 103
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 102
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia 100
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 99
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 98
High depression symptomatology and mental pain characterize suicidal psychiatric patients 96
Trends in alcohol-related deaths in the EU countries in 1980-2003 93
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. 91
Totale 20.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022950 0 91 33 53 59 44 52 176 64 69 132 177
2022/20232.918 279 309 204 366 210 278 191 302 357 100 170 152
2023/20241.910 143 358 103 141 125 246 84 105 78 115 192 220
2024/20252.917 172 145 218 171 268 129 138 188 430 222 428 408
2025/20266.416 732 214 286 548 1.013 381 1.062 459 428 608 298 387
2026/20271.749 822 927 0 0 0 0 0 0 0 0 0 0
Totale 21.851